1. Home
  2. TMDX vs TSLX Comparison

TMDX vs TSLX Comparison

Compare TMDX & TSLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • TSLX
  • Stock Information
  • Founded
  • TMDX 1998
  • TSLX 2010
  • Country
  • TMDX United States
  • TSLX United States
  • Employees
  • TMDX N/A
  • TSLX N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • TSLX Investment Managers
  • Sector
  • TMDX Health Care
  • TSLX Finance
  • Exchange
  • TMDX Nasdaq
  • TSLX Nasdaq
  • Market Cap
  • TMDX 4.8B
  • TSLX 2.1B
  • IPO Year
  • TMDX 2019
  • TSLX 2014
  • Fundamental
  • Price
  • TMDX $128.97
  • TSLX $23.83
  • Analyst Decision
  • TMDX Buy
  • TSLX Strong Buy
  • Analyst Count
  • TMDX 10
  • TSLX 8
  • Target Price
  • TMDX $127.33
  • TSLX $22.69
  • AVG Volume (30 Days)
  • TMDX 838.7K
  • TSLX 558.0K
  • Earning Date
  • TMDX 07-30-2025
  • TSLX 07-30-2025
  • Dividend Yield
  • TMDX N/A
  • TSLX 8.74%
  • EPS Growth
  • TMDX N/A
  • TSLX N/A
  • EPS
  • TMDX 1.41
  • TSLX 1.89
  • Revenue
  • TMDX $488,227,000.00
  • TSLX $481,092,000.00
  • Revenue This Year
  • TMDX $34.07
  • TSLX N/A
  • Revenue Next Year
  • TMDX $20.76
  • TSLX N/A
  • P/E Ratio
  • TMDX $92.35
  • TSLX $12.60
  • Revenue Growth
  • TMDX 64.43
  • TSLX 4.73
  • 52 Week Low
  • TMDX $55.00
  • TSLX $18.58
  • 52 Week High
  • TMDX $177.37
  • TSLX $23.98
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 59.35
  • TSLX 63.19
  • Support Level
  • TMDX $120.36
  • TSLX $22.76
  • Resistance Level
  • TMDX $133.49
  • TSLX $23.98
  • Average True Range (ATR)
  • TMDX 5.58
  • TSLX 0.35
  • MACD
  • TMDX -1.35
  • TSLX 0.01
  • Stochastic Oscillator
  • TMDX 60.26
  • TSLX 85.54

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

Share on Social Networks: